Year-round flu vaccinations promote healthier infants in subtropics

May 16, 2017, Cincinnati Children's Hospital Medical Center
A Nepalese member of an international flu vaccine research team surveys villagers in the subtropical terai plains of southern Nepal in Asia. The researchers report in The Lancet Infectious Diseases that vaccinating pregnant mothers year-round against flu in this resource-challenged region reduced infant flu virus infection rates by an average of 30 percent and increased birth weights by 15 percent. Credit: Cincinnati Children's

Vaccinating pregnant mothers year-round against flu in the resource-challenged region of subtropical Nepal reduced infant flu virus infection rates by an average of 30 percent, increased birth weights by 15 percent and resulted in babies having less influenza, according to a study published in The Lancet Infectious Diseases.

Reporting their data in a study published online May 15, an international research team says expanding year-round flu vaccinations during pregnancy would also benefit children in other tropical and subtropical parts of the world—where flu viruses can be pervasive and circulate 8 to 12 months a year.

"The development of a child inside the mother affects that child its entire life, and low birth weight has lifelong health implications for a child," says Mark Steinhoff, MD, corresponding author on the study and director of the Global Health Center at Cincinnati Children's Hospital Medical Center. "The overall positive effect of performing these vaccinations—which is not expensive—is quite significant."

Funded by the Bill and Melinda Gates Foundation (grant 50274), the research team focused its study on the subtropical terai plains of southern Nepal in south Asia. This underdeveloped, agrarian region is known for a subsistence lifestyle, high rates of malnutrition and limited access to healthcare, and is representative of many tropical regions where 40% of the worlds births occur,

Village visits

Researchers traveled to villages in southern Nepal during normal routine health visits by Nepalese members of the team. Participating households were then followed up and surveilled on a weekly basis during home visits. Collaborating on the study were researchers from the Nepal Nutrition Intervention Project and the Tribhuvan University Institute of Medicine, both based in the Nepalese capital of Kathmandu.

In households where women between the ages of 15 and 40 were pregnant, volunteer participants were administered either influenza vaccine or placebo as part of a randomized, placebo-controlled Phase 4 clinical trial. The trial was registered with and the protocol was reviewed and approved by the institutional review boards of participating institutions. From April 2011 through September 2013, 3,693 were recruited and randomized into two different annual research groups (or cohorts).

In the first cohort of 2,090, 1,040 mothers were given placebo, and 1,049 were administered seasonally recommended trivalent inactivated vaccine (which contains three inactivated flu viruses). In the second cohort of 1,603 mothers, 805 were given placebo and 798 received vaccine. There were a total of 3,646 live births in both groups.

The researchers assessed three primary outcomes: the incidence of laboratory confirmed infant influenza from 0-180 days post birth; the incidence of low birth weight; and the incidence of influenza-like illness in mothers 0-180 days following delivery.

In cohort 1, compared to the placebo group influenza-like illness was reduced by 9 percent in pre- and post-partum mothers who received vaccine. In cohort 2, flu-like illness was reduced by 36 percent. This placed the average flu reduction rate for both groups of vaccinated mothers at 19 percent.

For infants, lab-confirmed flu infections in cohort 1 decreased 16 percent in babies with vaccinated mothers. In cohort 2 they decreased by 60 percent—putting the average rate of reduction for both cohorts at 30 percent.

As for birth weight, flu immunizations in reduced the rate of (less than 2,500 grams/5.5 pounds) by 15 percent in cohort 1 and by 15 percent in cohort 2 (average 15 percent for both groups).

There were 111 infant deaths during the study—50 in the placebo group and 51 in the vaccine group; and seven maternal deaths—five in the and two in the vaccine group.

Follow up

Researchers are following up their current study by gathering additional data to support the expansion of year-round flu vaccination to other regions where it is needed. Steinhoff said this is especially important for developing countries like Nepal and where influenza has a more significant impact on birth weights than in developed nations.

An estimated 40 percent of the world's population lives in subtropical/tropical zones, although is not widely used in these areas, according to the authors. The benefits of vaccinating pregnant women is well documented in developed countries. Its use has not been prevalent in underdeveloped subtropical/tropical regions, where many local officials have believed until recently that influenza virus does not even exist.

Climatic conditions

Study authors note that the timing, circulation and type of flu virus are highly variable in subtropical and tropical regions.

During the current study in Nepal, the circulation of flu increased during the South Asian Southwest monsoon season in July-October. Active symptomatic flu virus was present among study participants for 24 (or 66 percent) of the study months, with two more strains of virus circulating during 18 of these months.

Researchers also pointed out that most of positive effect from flu vaccination was observed in the second study group of mothers and infants. This second group received two different formulations of flu vaccine with a broader range of antigens to account for virus variability in the region.

This high variability of influenza virus in the study region (and other subtropical/tropical climates) will require improved vaccines with broader antigenic coverage, the authors report.

Explore further: Influenza vaccination of pregnant women helps their babies

More information: Mark C Steinhoff et al, Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial, The Lancet Infectious Diseases (2017). DOI: 10.1016/S1473-3099(17)30252-9

Related Stories

Influenza vaccination of pregnant women helps their babies

February 21, 2012
Vaccinating pregnant women against the influenza virus appears to have a significant positive effect on birth weight in babies, according to a study published in CMAJ (Canadian Medical Association Journal).

Seasonal influenza vaccination during pregnancy may reduce risk of stillbirth

March 31, 2016
Seasonal influenza vaccination may guard against stillbirth, a new study published in Clinical Infectious Diseases and available online suggests. Researchers in Western Australia analyzed data from nearly 60,000 births that ...

Maternal vaccination again influenza associated with protection for infants

July 5, 2016
How long does the protection from a mother's immunization against influenza during pregnancy last for infants after they are born?

New study finds that vaccinating mothers against flu can protect newborns

June 2, 2016
Each year, influenza causes between 250,000 and half a million deaths around the world. Pregnant women and young infants have a higher risk of complications related to influenza; these complications can easily lead to death. ...

Infants much less likely to get the flu if moms are vaccinated while pregnant

May 3, 2016
Babies whose moms get flu vaccinations while pregnant have a significantly reduced risk of acquiring influenza during their first six months of life, a new study shows, leading the authors to declare that the need for getting ...

Expert advises preparing for flu season now

September 13, 2016
The news that the nasal spray form of the influenza vaccine will not be available this year should not stop anyone from getting vaccinated against the flu virus, according to an expert at Baylor College of Medicine's Influenza ...

Recommended for you

Lung-on-a-chip simulates pulmonary fibrosis

May 25, 2018
Developing new medicines to treat pulmonary fibrosis, one of the most common and serious forms of lung disease, is not easy.

Reconstructing Zika's spread

May 24, 2018
The urgent threat from Zika virus, which dominated news headlines in the spring and summer of 2016, has passed for now. But research into how Zika and other mosquito-borne infections spread and cause epidemics is still very ...

Tick bite protection: New CDC study adds to the promise of permethrin-treated clothing

May 24, 2018
The case for permethrin-treated clothing to prevent tick bites keeps getting stronger.

Molecular network boosts drug resistance and virulence in hospital-acquired bacterium

May 24, 2018
In response to antibiotics, a gene regulation network found in the bacterium Acinetobacter baumannii acts to boost both virulence and antibiotic resistance. Edward Geisinger of Tufts University School of Medicine and colleagues ...

Past use of disinfectants and PPE for Ebola could inform future outbreaks

May 24, 2018
Data from the 2014 Ebola virus outbreak at two Sierra Leone facilities reveal daily usage rates for disinfectant and personal protective equipment, informing future outbreaks, according to a study published May 24, 2018 in ...

Early lactate measurements appear to improve results for septic patients

May 24, 2018
On October 1, 2015, the United States Centers for Medicare and Medicaid Services (CMS) issued a bundle of recommendations defining optimal treatment of patients suffering from sepsis, a life-threatening response to infection ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.